Notorious "pharma bro" Martin Shkreli has reached a settlement with his former biopharmaceutical company Retrophin to resolve "all outstanding disputes" just week after he sued two company directors and its ex-general counsel from prison.
Notorious "pharma bro" Martin Shkreli, settled in to his new home in a federal prison in Pennsylvania, on Friday sued two directors and the ex-general counsel of Retrophin, accusing them of using fraud to oust him as head of the firm in 2014.
Wu-Tang Clan's RZA said he "would love" to get back the hip-hop group's single-copy album, which was ordered forfeited to the federal government.
Rza and the Wu-Tang Clan join CNBC's "Closing Bell" team to discuss the group's premiere of their new Showtime docu-series, "Wu-Tang: Of Mics and Men." Wu-Tang Clan is ringing the closing bell at the New York Stock Exchange to celebrate the series.
Notorious drug-company fraudster Martin Shkreli has been removed from a federal prison in Fort Dix, New Jersey, after claims that he was running his pharmaceuticals firm Phoenixus while locked up with the help of a contraband cellphone.
NEW YORK, March 8- The U.S. Bureau of Prisons said on Friday it was investigating former drug company executive Martin Shkreli's conduct in prison after the Wall Street Journal reported he was still helping run his old company using a contraband cellphone. The Journal reported on Thursday that Shkreli, 35, still wields significant influence over the drug...
To many, the character of Barry Cohen in Shteyngart's new novel, "Lake Success," will bear some resemblances to hedge fund titans like Steve Cohen or Bill Ackman.
Rep. Francis Rooney, a Republican, just signed on to the FAIR Drug Pricing Act, a bill that requires basic transparency for pharmaceutical companies that drastically spike the price of a drug.
The Food and Drug Administration is forming a working group to consider allowing short-term importation of foreign versions of medicines facing “access dislocations.”
New York's attorney general said state tax authorities are entitled to first dibs on more than $480,000 out of the nearly $7.4 million Shkreli was ordered to forfeit as regulators reveal Shrkreli had agreed to be barred from the securities industry.
Shkreli had asked for a minimum security camp to complete his seven-year sentence for defrauding hedge-fund investors and manipulating the stock of the drug company Retrophin.
Shkreli had asked for a minimum security camp to complete his seven-year sentence for defrauding hedge-fund investors and manipulating the stock of the drug company Retrophin.
Shkreli, who raised the price of the drug Daraprim by more than 5,000 percent, has been locked up since offering a bounty to his Facebook followers for strands of Hillary Clinton's hair.
Shkreli, who gained infamy for raising the price of the drug Daraprim by more than 5,000 percent, has been locked up since offering a bounty for hair stolen by Facebook followers from the head of Hillary Clinton.
Martin Shkreli was sentenced to seven years in prison for securities fraud charges related to a drug company he founded and two hedge funds he had run.
Shkreli wants to serve his seven-year prison sentence at the minimum-security camp at Canaan Federal Penitentiary in Pennsylvania.
Shkreli wants to serve his seven-year prison sentence at the minimum-security camp at Canaan Federal Penitentiary in Pennsylvania.
CNBC's Meg Tirrell reports the details of 'Pharma Bro' Martin Shkreli's seven-year prison sentence for securities fraud.
Ron Cohen, Acorda Therapeutics founder, discusses the impact that 'Pharma Bro' Martin Shkreli has had on the pharmaceutical industry.
Benjamin Brafman, lawyer for 'Pharma Bro' Martin Shkreli, speaks after the sentencing hearing for Shrkeli's securities fraud charges.
Data also provided by 
